(Total Views: 427)
Posted On: 03/05/2020 10:03:42 AM
Post# of 153988
Thanks Ohm,
One of the rans of the naysayers is: "to good to be true". Have seen some ignorant comments in articles all over, in other sites, regarding the ability of Leronlimab to help with so many indications.
If they will take the time to read a little bit and start asking themselves some questions we wouldn't have this type of comments in those other boards and pseudo-serious publications.
Granted, it might be that Leronlimab can help more in some and not as much in others due to the very complex characteristics of cancer, but the MOA ,I believe, has been demonstrated and documented beyond any possible doubt.
At least for me.
So, we should continue in the quest to bring this drug to patients. Not doing it will be dereliction of duty, to put it in some way.
One of the rans of the naysayers is: "to good to be true". Have seen some ignorant comments in articles all over, in other sites, regarding the ability of Leronlimab to help with so many indications.
If they will take the time to read a little bit and start asking themselves some questions we wouldn't have this type of comments in those other boards and pseudo-serious publications.
Granted, it might be that Leronlimab can help more in some and not as much in others due to the very complex characteristics of cancer, but the MOA ,I believe, has been demonstrated and documented beyond any possible doubt.
At least for me.
So, we should continue in the quest to bring this drug to patients. Not doing it will be dereliction of duty, to put it in some way.
(0)
(0)
